|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, amortization and accretion | |||||
| Gain on sale on disposal of discontinued operations | |||||
| Impairments and other charges | |||||
| Gain on investments | |||||
| Realized gain on sale of Standard Lithium shares | |||||
| Deferred income tax expense (benefit) | |||||
| Equity-based compensation expense | |||||
| Provision for credit losses | |||||
| Loss on debt extinguishment | |||||
| Amortization and expense of financing costs | |||||
| Insurance recoveries associated with damaged equipment | |||||
| Non-cash cumulative foreign currency translation adjustment loss from dissolution of Canadian subsidiary | |||||
| Gain on sale of assets | |||||
| Other non-cash credits | |||||
| Changes in operating assets and liabilities, net of assets acquired: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Trade accounts payable and accrued expenses | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchases of property, plant and equipment, net | |||||
| Acquisition of businesses, net | |||||
| Purchases of investments | |||||
| Proceeds from sale of investments | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Proceeds from insurance recoveries associated with damaged equipment | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Proceeds from credit agreements and long-term debt | |||||
| Principal payments on credit agreements and long-term debt | |||||
| Payments on finance lease obligations | |||||
| Debt issuance costs | |||||
| Taxes paid upon vesting of equity-based compensation | |||||
| Proceeds from exercise of stock options | |||||
| Other financing activities | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash and cash equivalents at beginning of period associated with discontinued operations | |||||
| Cash and cash equivalents at beginning of period associated with continuing operations | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets | |||||
| Cash and cash equivalents at end of period | |||||
| Restricted cash at end of period | |||||
Loading...